Fosun Pharmaceutical bought Concert Pharmaceuticals Shanghai Fosun Pharmaceutical from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Shanghai Fosun Pharmaceutical

2196

HK$13.72

0.00%

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

Sovcombank finalizes negotiations on the purchase of Absolut Insurance

9/24/24 SVCB

VK launches big data platform

9/24/24 VKCO

Shareholders of TNS Energy Mari El approved dividends

9/23/24 MISB

Petr Ivanov appointed as President of Fesco

9/23/24 FESH

Shareholders of TNS power Rostov-on-Don approved dividends

9/23/24 RTSB

Nornickel may invest in mining projects in Kazakhstan

9/23/24 GMKN

Shareholders of TNS energy Voronezh approved dividends

9/23/24 VRSB

TGC-14 holds SPO

9/23/24 TGKN

Gazprom to maximize supplies through the Power of Siberia ahead of schedule

9/20/24 GAZP

Shareholders of Avangard Bank approved dividends

9/20/24 AVAN